Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Akorn Inc (AKRX)

Akorn Inc (AKRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 81,416
  • Shares Outstanding, K 126,246
  • Annual Sales, $ 682,430 K
  • Annual Income, $ -226,770 K
  • 60-Month Beta 1.75
  • Price/Sales 0.12
  • Price/Cash Flow 1.38
  • Price/Book 0.40
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings 0.02 on 10/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +713,671.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3687 +74.91%
on 03/18/20
1.3000 -50.39%
on 03/02/20
-0.5151 (-44.41%)
since 02/28/20
3-Month
0.3687 +74.91%
on 03/18/20
1.8400 -64.95%
on 02/10/20
-0.7151 (-52.58%)
since 12/27/19
52-Week
0.3687 +74.91%
on 03/18/20
5.4600 -88.19%
on 06/28/19
-2.8751 (-81.68%)
since 03/29/19

Most Recent Stories

More News
Global Dry Eye Syndrome Treatment Market Worldwide Survey On Product Need 2029 - Alcon, Allergan and Novartis AG

Global Dry Eye Syndrome Treatment Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property Analysis,...

ABT : 79.34 (+6.41%)
AKRX : 0.6449 (+0.26%)
NVS : 81.90 (+3.30%)
VRX.TO : 30.80 (-3.33%)
Akorn: 4Q Earnings Snapshot

LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Wednesday reported a loss of $80.7 million in its fourth quarter.

AKRX : 0.6449 (+0.26%)
Akorn Provides Fourth Quarter and Full Year 2019 Results

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2019.

AKRX : 0.6449 (+0.26%)
Akorn (AKRX) to Report Q4 Earnings: What's in the Cards?

Akorn's (AKRX) fourth-quarter 2019 results are likely to reflect a decline in sales volume due to stiffening competition.

AMAG : 6.17 (+3.87%)
AKRX : 0.6449 (+0.26%)
SAGE : 29.50 (-6.35%)
VCEL : 9.24 (-1.60%)
Akorn Inc Set to Possibly Rebound After Yesterday's Selloff of 11.38%

Akorn Inc (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $1.22 to a high of $1.33. Yesterday, the shares fell 11.4%, which took the trading range below the 3-day low of $1.42 on...

AKRX : 0.6449 (+0.26%)
Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced it has reached an agreement with certain of its lenders to extend the standstill period. The agreement defines a...

AKRX : 0.6449 (+0.26%)
Lowenstein's Securities Litigation Group Defeats Motion to Dismiss Securities Fraud Opt-Out Suits Against Akorn, Inc.

The U.S. District Court for the Northern District of Illinois denied defendant Akorn, Inc.'s motion to dismiss two securities fraud lawsuits brought by several investment funds represented by Lowenstein...

AKRX : 0.6449 (+0.26%)
Akorn Continues Negotiations with Lenders

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today confirmed that negotiations with certain of its lenders are ongoing following the expiration of its standstill agreement on...

AKRX : 0.6449 (+0.26%)
Watch for Akorn Inc to Potentially Pullback After Gaining 7.84% Yesterday

Akorn Inc (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $1.52 to a high of $1.65. Yesterday, the shares gained 7.8%, which took the trading range above the 3-day high of $1.63...

AKRX : 0.6449 (+0.26%)
Look for Shares of Akorn Inc to Potentially Pullback after Yesterday's 4.85% Rise

Akorn Inc (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $1.36 to a high of $1.42. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $1.39...

AKRX : 0.6449 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AKRX with:

Business Summary

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals,...

See More

Key Turning Points

2nd Resistance Point 0.7667
1st Resistance Point 0.7058
Last Price 0.6449
1st Support Level 0.5720
2nd Support Level 0.4991

See More

52-Week High 5.4600
Fibonacci 61.8% 3.5151
Fibonacci 50% 2.9144
Fibonacci 38.2% 2.3136
Last Price 0.6449
52-Week Low 0.3687

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar